Evidence map›Paper›PMID 27731539›Full record

ArticleChembiochem : a European journal of chemical biology2016

Guide Strand 3'-End Modifications Regulate siRNA Specificity.

Rachel A P Valenzuela, Kazumitsu Onizuka, Alexi A Ball-Jones, Tiannan Hu, Scott R Suter, Peter A Beal

Open access · greenAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Clickable RNA via 4'-Bioconjugate chemistry · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rachel A P ValenzuelaDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA, 95616, USA.
Kazumitsu OnizukaDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA, 95616, USA.
Alexi A Ball-JonesDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA, 95616, USA.
Tiannan HuDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA, 95616, USA.
Scott R SuterDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA, 95616, USA.
Peter A BealDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA, 95616, USA.
University of California, Davis · US

Funding

Nucleobase analogs for next generation siRNAsR01GM080784 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BEAL, PETER A. · 2007 to 2020
$3.5M
BRIDGES TO THE PROFESSORIATET36GM008784 · NIGMS · WESTERN INTERSTATE COMMISSION HIGHER ED · PI PEPION, KENNETH · 2000 to 2015
$2.9M
NIGMS NIH HHS R01 GM080784NIGMS NIH HHS T36 GM008784
6 · The paper itself

Abstract

Short interfering RNA (siRNA)-triggered gene knockdown through the RNA interference (RNAi) pathway is widely used to study gene function, and siRNA-based therapeutics are in development. However, as the guide strand of an siRNA can function like a natural microRNA (miRNA), siRNAs often repress hundreds of off-target transcripts with complementarity only to the seed region (nucleotides 2-8) of the guide strand. Here, we describe novel guide strand 3'-end modifications derived from 1-ethynylribose (1-ER) and copper-catalyzed azide-alkyne cycloaddition reactions and evaluate their impact on target versus miRNA-like off-target knockdown. Surprisingly, when positioned at the guide strand 3'-end, the parent 1-ER modification substantially reduced off-target knockdown while having no measurable effect on on-target knockdown potency. In addition, these modifications were shown to modulate siRNA affinity for the hAgo2 PAZ domain. However, the change in PAZ domain binding affinity was not sufficient to predict the modification's effect on miRNA-like off targeting.

Indexed as

RNA Interference3' Flanking RegionAlkynesArgonaute ProteinsAzidesCatalysisClass I Phosphatidylinositol 3-KinasesCopperCycloaddition ReactionHeLa CellsHumansMicroRNAsPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProtein DomainsRNA, Small InterferingAGO2 protein, humanAlkynesArgonaute ProteinsAzidesClass I Phosphatidylinositol 3-KinasesCopperMicroRNAsPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPIK3CB protein, humanRNA, Small Interferingclick chemistrynucleoside analogueoff targetingPAZ domainsiRNA

Identifiers

PMID27731539
PMCPMC5161629
OpenAlexW2530045699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.